CA2047203A1 - Fibroblast growth factor for use in the prevention and treatment of viral infections - Google Patents

Fibroblast growth factor for use in the prevention and treatment of viral infections

Info

Publication number
CA2047203A1
CA2047203A1 CA002047203A CA2047203A CA2047203A1 CA 2047203 A1 CA2047203 A1 CA 2047203A1 CA 002047203 A CA002047203 A CA 002047203A CA 2047203 A CA2047203 A CA 2047203A CA 2047203 A1 CA2047203 A1 CA 2047203A1
Authority
CA
Canada
Prior art keywords
virus
use according
ser
bfgf
fibroblast growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047203A
Other languages
English (en)
French (fr)
Inventor
Maria A. Verini
Domenico Ungheri
Carlo Battistini
Paolo Carminati
Guy Mazue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2047203A1 publication Critical patent/CA2047203A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002047203A 1989-12-22 1990-12-18 Fibroblast growth factor for use in the prevention and treatment of viral infections Abandoned CA2047203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02280489A IT1237795B (it) 1989-12-22 1989-12-22 Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali.
IT22804A/89 1989-12-22

Publications (1)

Publication Number Publication Date
CA2047203A1 true CA2047203A1 (en) 1991-06-23

Family

ID=11200616

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047203A Abandoned CA2047203A1 (en) 1989-12-22 1990-12-18 Fibroblast growth factor for use in the prevention and treatment of viral infections

Country Status (10)

Country Link
EP (1) EP0460161A1 (it)
JP (1) JPH04504581A (it)
AU (1) AU632890B2 (it)
CA (1) CA2047203A1 (it)
HU (1) HUT62197A (it)
IE (1) IE904593A1 (it)
IL (1) IL96667A0 (it)
IT (1) IT1237795B (it)
WO (1) WO1991009610A1 (it)
ZA (1) ZA9010337B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
DK1344829T3 (da) 2000-11-27 2008-09-01 Dnavec Research Inc Paramyxovirusvektor kodende for fibroblastvækstfaktor 2 (FGF2) og anvendelse deraf
JP6363833B2 (ja) * 2013-11-22 2018-07-25 ナノシータ株式会社 薄膜状高分子構造体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593065B1 (en) * 1985-09-12 2002-08-21 Scios Inc. Recombinant fibroblast growth factors
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials

Also Published As

Publication number Publication date
WO1991009610A1 (en) 1991-07-11
IT1237795B (it) 1993-06-17
HUT62197A (en) 1993-04-28
HU913022D0 (en) 1992-01-28
IT8922804A0 (it) 1989-12-22
AU6970491A (en) 1991-07-24
IE904593A1 (en) 1991-07-03
JPH04504581A (ja) 1992-08-13
EP0460161A1 (en) 1991-12-11
ZA9010337B (en) 1991-10-30
IL96667A0 (en) 1991-09-16
AU632890B2 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
US5288704A (en) Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent
AU617126B2 (en) A polypeptide growth factor from milk
US5436228A (en) Chemotactic wound healing peptides
US5461034A (en) Osteogenic growth polypeptides identified from regenerating bone marrow
EP0797590B1 (en) Neurotrophic peptides of activity dependent neurotrophic factor
KR20010049676A (ko) 에리트로포이에틴 컨쥬게이트
JPH05506030A (ja) 哺乳動物に組織修復促進の傾向を与える方法
JPH0699322B2 (ja) 傷の治癒
US5633230A (en) Treatment of cytomegalovirus infection
US5824647A (en) Chemotactic wound healing peptides
IE65533B1 (en) Hemoregulatory peptides
JPH05500356A (ja) 創傷の治癒
KR20000015895A (ko) 타입-2 케모카인 결합 단백질 및 그 이용방법
CN114773428A (zh) 新多肽及其在制备治疗皮肤创面或黏膜损伤药物中的应用
AU632890B2 (en) Fibroblast growth factor for use in the prevention and treatment of viral infections
EP0384731B1 (en) Osteogenic growth polypeptides identified from regenerating bone marrow
AU685862B2 (en) Treatment of cytomegalovirus infection
US6869925B1 (en) Inhibition of retrovirus infection
CA2317107C (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
CA2327811A1 (en) Short peptides for treatment of neurological degenerative diseases
US5059418A (en) Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
WO1992021362A1 (en) Nerve growth factor for use in the prevention and treatment of viral infections
WO2002029082A1 (en) Endothelial cell mitogen bioassay
EP4032901A1 (en) Recombinant human neuregulin derivatives and use thereof
EP0557319A1 (en) THERAPEUTIC USE OF THE FIBROBLAST GROWTH FACTOR.

Legal Events

Date Code Title Description
FZDE Discontinued